| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| Bandhan Healthcare Fund IDCW Payout |
| [Equity: Sectoral] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
0.90 |
| Equity |
96.71 |
| Trep |
2.39 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
37.43% |
| Top 10 Holdings |
56.21% |
| Top 25 Holdings |
88.99% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
65.67 |
| Healthcare |
28.3 |
| Cash |
3.29 |
| Miscellaneous |
2.48 |
| Software & Services |
0.26 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
5.72 |
| PE Ratio |
41.80 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| Sun Pharmaceutical Industries Limited |
10.11 |
| Apollo Hos Ent Ltd |
8.08 |
| Cipla Limited |
6.82 |
| Max Healthcare Institute Limited |
6.30 |
| DIVI LABORATORIES LTD |
6.12 |
| J B Chemicals and Pharma Ltd |
4.27 |
| Dr Reddys Laboratories Limited |
4.21 |
| Aurobindo Pharma Limited |
3.92 |
| Glenmark Pharmaceuticals Limited |
3.42 |
| Dr Lal Path Labs Ltd |
2.96 |
| Ajanta Pharma Limited |
2.87 |
| EQ- GLOBAL HEALTH LTD. |
2.85 |
| Shilpa Medicare Limited |
2.78 |
| Zydus Lifesciences Limited |
2.74 |
| Triparty Repo TRP_010726 |
2.39 |
| GLAXO SMITHKLINE PHARMA |
2.28 |
| Rainbow Childrens Medicare Limited |
2.19 |
| Eris Lifesciences Limited |
2.01 |
| Abbott India Limited |
1.97 |
| Healthcare Global Enterprises Limited |
1.94 |
| IPCA Laboratories Limited |
1.85 |
| Pfizer Limited |
1.79 |
| Syngene International Limited |
1.77 |
| Lupin Limited |
1.69 |
| Orchid Pharma Limited |
1.66 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|